OPERATING ROOM
with increases in HAIs, such as central line-associated bloodstream infections (CLABSIs). Now it is of utmost importance that we arm staff with education and tools to ensure they are well versed in the basic infection prevention practices. To encourage good outcomes
and compliance, a robust monitoring of infection prevention processes, along with constructive feedback is also essential.” HPN
References at
https://hpnonline.com/21222173 Measures and tools to control SSIs and HAIs
How have hospitals and healthcare facilities protected patients against cross-contamination and infections? Industry representatives share these insights.
“The Crothall EVS team plays a critical role in healthcare-associated infection (HAI) prevention at Virginia Mason Medical Center. Every tool, product, protocol and training we employ is designed to impact HAI incidence. The EVS team has a shared responsibility with the organiza- tion to stop HAIs by prioritizing areas that pose immediate safety risks. Our EVS team has identifi ed fi ve pillars that help prevent HAIs: hand hygiene, process, measurement, augmentation and emerging solutions. The EVS management team performs monthly and annual trainings with all employees. The team also partners with the hospital’s Infection Preventionist to review monthly inspections and adenosine triphosphate (ATP) swab testing results. ATP monitoring is a rapid-test method we use to assess the cleanliness of surfaces.” Brian Byers, Director of Environmental
Services, Virginia Mason Medical Center, which contracts with Crothall Healthcare for on-site environmental services. Byers was part of
the center’s Eliminate Health Care-Associated Infections Team, which won the center’s 2020 Mary McClinton Patient Safety Award.
“The CDC found that there were an estimated 110,800 SSIs associated with inpatient surgeries in 2015. Of those SSIs, S. aureus was the most prevalent SSI pathogen for most types of surgery.6
The CDC’s ‘Strate-
gies to Prevent Hospital-onset Staphylococcus aureus Bloodstream Infections in Acute Care Facilities’ recommends skin decolonization with chlorhexidine gluconate (CHG) and nasal decolonization with an antibi- otic or an iodophor (povidone iodine) antiseptic for prevention of device- associated infections, as well as SSIs. This decolonization strategy would be appropriate for high-risk surgical patients and high-risk patients in the ICU setting, or patients with central or midline vascular catheters.7 Three
months after Duke Raleigh Hospital implanted povidone iodine nasal decolonization in their orthopedic surgeries, they had a 60% decrease in SSIs.8
PDI’s Profend Nasal Decolonization Kit
They found ‘preoperative
nasal povidone iodine decolonization to be a safe, effi cient and cost- effective strategy in reducing SSIs in elective orthopedic surgeries.’”8 Deva Rea, PDI Healthcare
“AORN issued infection prevention guide- lines that recommend covering the sterile fi eld during periods of prolonged, ambient exposure to protect against airborne con- taminants. As advanced infection preven- tion technologies come to market, surgical teams can evaluate and adopt products that automate infection prevention. SurgiSLUSH delivers a fully automated, closed system with sealed containers to cover and protect slush until needed, erasing prolonged expo- sure and sterile barrier surprises.” Patrick Kammer, C Change Surgical
SurgiSLUSH - C Change Surgical
“Through the use of the Soteria Bed Barrier, hospitals have been able to decrease their infection rates and keep patients safer as well as extend the life of their mattresses. Customers have reported C. diff reductions between 30-50%. Our peer-reviewed research shows that hospitals can achieve a 99.9999% reduction in harmful pathogens on the mattress surface and up to a 50% reduction in C. diff infections without increasing pressure injuries when using the barrier. Research shows disinfection methods incapable of producing a 99.9999% reduction of spores puts patients at risk of acquiring C. diff. The barrier process allows hospitals to focus on providing quality patient care while decreasing patient risk.” Bruce Rippe, Trinity Guardion, Inc.
“Our customers have worked to decrease and control bacterial, viral or other contaminants by partnering with Ansell for process improvement and product solutions. We offer a variety of continuing education programs and have as- sisted our customers with AnsellAdvisOR to help mitigate infection risks by identifying op- portunities to improve safety, increase effi cien- cy and reduce costs. Product solutions, such as antimicrobial linens, provide an added layer of protection from pathogens. Ansell’s STAT- BLOC Antimicrobial Linens have been tested and proven to kill 99% of COVID-19 when exposed to the antimicrobial backing and are 99.9% effective against MRSA, CRE and
E.coli.”9
Ansell STAT-PAC O.R. Turnover Solutions Dana Goossen, Ansell Healthcare
“One of the biggest challenges we hear as it relates to hand hygiene com- pliance is securing sustained compliance, which, of course, is key to the long-term advancement of infection reduction. That sustained compliance requires a comprehensive approach to hand hygiene performance management that balances leadership engagement, education, posi- tive feedback, individual accountability and ease of use, such as provided by GP PRO’s SafeHaven Personal Hand Hygiene System. In fact, early clinical trials of the SafeHaven System showed a 183% increase in hand hygiene events with more than six months of sustained compliance improvement.”
GP PRO’s SafeHaven
Personal Hand Hygiene System
Eric Jungslager, GP PRO
“Far UV Krypton disinfection lights can be used to reduce the viral load in an operating room and dramatically reduce the risk of infections. These lights are safe and effective to be used in occupied spaces for disinfection of air and surfaces.” Shawn Malek, Far UV Technologies, Inc.
18 June 2021 • HEALTHCARE PURCHASING NEWS •
hpnonline.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66
